
Bloomage BioTechnology Corporation Limited
SSE:688363.SS
48.84 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| 168.406 | 582.742 | 961.38 | 775.556 | 645.011 | 584.615 | 423.86 | 222.269 | 269.429 | 190.393 | 162.067 | 94.398 | 89.272 |
Depreciation & Amortization
| 300.003 | 264.653 | 213.611 | 154.331 | 70.185 | 60.399 | 46.881 | 42.944 | 34.868 | 40.245 | 14.111 | 12.762 | 10.384 |
Deferred Income Tax
| 0 | -34.959 | -61.781 | -150.168 | -50.187 | -22.672 | -6.517 | -1.378 | 0.764 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 90.978 | 97.883 | 0 | 0 | 22.13 | 47.469 | 23.32 | 26.538 | 26.549 | 57.285 | 0.182 |
Change In Working Capital
| -149.078 | -288.129 | -670.873 | 208.409 | -25.228 | -292.336 | -26.542 | 23.938 | -79.71 | -121.804 | -101.362 | -35.719 | -26.233 |
Accounts Receivables
| -86.546 | 54.482 | -98.427 | -36.273 | -64.938 | -181.361 | 18.295 | -8.948 | -108.882 | -81.642 | -88.798 | -25.923 | -23.927 |
Inventory
| -141.487 | 13.884 | -437.816 | -218.534 | -178.515 | -141.701 | -19.569 | 12.132 | -47.067 | -62.51 | -12.564 | -9.796 | -2.306 |
Accounts Payables
| 0 | -321.536 | -72.849 | 613.385 | 268.412 | 53.398 | -18.751 | 22.132 | 75.476 | 22.348 | 0 | 0 | 0 |
Other Working Capital
| 78.956 | -34.959 | -61.781 | -150.168 | -50.187 | -22.672 | -6.973 | 11.806 | -32.642 | 0 | 0 | 0 | 0 |
Other Non Cash Items
| 245.174 | 175.341 | 88.996 | 190.049 | 15.153 | 12.214 | -1.898 | 54.27 | 17.088 | 239.128 | 36.108 | 26.601 | -16.038 |
Operating Cash Flow
| 564.505 | 699.648 | 635.189 | 1,276.06 | 705.121 | 364.892 | 442.3 | 343.421 | 241.675 | 145.668 | 137.473 | 155.327 | 83.618 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -721.388 | -1,030.331 | -696.411 | -784.209 | -762.775 | -450.228 | -168.422 | -46 | -19.914 | -266.974 | -118.449 | -114.127 | -46.528 |
Acquisitions Net
| 0 | 0 | -155.031 | -138.085 | 0.061 | 803 | -431.658 | 0.008 | 0.21 | -35.723 | 0 | 0 | 0 |
Purchases Of Investments
| -287.978 | -176.206 | -123.308 | -1.96 | -10.94 | -803 | 0 | 0 | 0 | -230.083 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 32.79 | 13.781 | 32.586 | 32.526 | 38.285 | 2.78 | 29.174 | 6.632 | 1.573 | 80 | 0 | 0 | 0 |
Other Investing Activites
| 515.21 | 572.092 | 105.942 | -98.136 | -595.939 | -800 | 536.385 | -289.132 | 0.686 | -27.973 | 47.027 | -53.515 | -93.731 |
Investing Cash Flow
| -461.366 | -620.664 | -836.222 | -989.864 | -1,331.308 | -1,247.448 | -34.52 | -328.5 | -17.655 | -445.03 | -71.422 | -167.642 | -140.259 |
Financing Activities: | |||||||||||||
Debt Repayment
| 35.714 | -106.363 | 101.115 | 157.815 | 23.836 | -40 | 40 | -220 | 220 | 834.179 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 163.65 | 3.914 | 0 | 0.246 |
Common Stock Repurchased
| 0 | -105.891 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -185.929 | -305.485 | -235.732 | -196.8 | -177.6 | 0 | -1,009.782 | -15.758 | -11.538 | -6.578 | -4.96 | -5.043 | -2.789 |
Other Financing Activities
| -160.303 | -121.719 | -40.83 | -42.35 | -6.173 | 2,263.891 | 1,055 | 5 | -0 | 163.65 | -46.627 | 67.855 | -8.48 |
Financing Cash Flow
| -310.519 | -533.566 | -170.157 | -71.356 | -159.937 | 2,223.891 | 85.218 | -230.758 | 208.462 | 991.251 | -47.673 | 62.812 | -11.023 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 7.812 | 10.565 | 29.556 | -19.851 | -12.354 | 6.167 | 16.05 | -9.855 | 5.21 | 10.518 | 0.033 | -1.878 | -0.336 |
Net Change In Cash
| -199.568 | -430.235 | -341.634 | 194.988 | -798.479 | 1,347.502 | 509.047 | -225.692 | 437.692 | 718.21 | 18.411 | 48.619 | -68 |
Cash At End Of Period
| 613.492 | 813.06 | 1,243.295 | 1,584.93 | 1,389.942 | 2,188.42 | 840.919 | 331.871 | 557.563 | 906.05 | 187.84 | 169.429 | 120.81 |